MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

90.23 0.69

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

89.61

Max

92.62

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+45.43% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.8B

11B

Ankstesnė atidarymo kaina

89.54

Ankstesnė uždarymo kaina

90.23

Naujienos nuotaikos

By Acuity

50%

50%

159 / 348 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-20 23:49; UTC

Svarbiausios naujienos

New Zealand 1Q Inflation Higher Than Expected

2026-04-20 23:10; UTC

Karštos akcijos

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

2026-04-20 22:53; UTC

Pagrindinės rinkos jėgos

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

2026-04-20 23:45; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

2026-04-20 23:44; UTC

Rinkos pokalbiai

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

2026-04-20 23:39; UTC

Rinkos pokalbiai

Rio Tinto Posts Strong Start to Year -- Market Talk

2026-04-20 23:30; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-20 23:30; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-20 23:30; UTC

Rinkos pokalbiai

Super Retail's Earnings Outlook Less Rosy -- Market Talk

2026-04-20 23:09; UTC

Rinkos pokalbiai

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

2026-04-20 22:31; UTC

Įsigijimai, susijungimai, perėmimai

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026-04-20 22:26; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

2026-04-20 22:25; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

2026-04-20 22:25; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Aims for Acquisition to Be Completed by End-2026

2026-04-20 22:25; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

2026-04-20 22:25; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Says Acquisition Would Be for A$175 Million

2026-04-20 22:24; UTC

Įsigijimai, susijungimai, perėmimai

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

2026-04-20 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

2026-04-20 22:01; UTC

Įsigijimai, susijungimai, perėmimai

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

2026-04-20 21:38; UTC

Rinkos pokalbiai

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

2026-04-20 21:33; UTC

Įsigijimai, susijungimai, perėmimai

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

2026-04-20 21:24; UTC

Rinkos pokalbiai

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

2026-04-20 21:24; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-20 21:13; UTC

Uždarbis

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

2026-04-20 21:10; UTC

Uždarbis

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

2026-04-20 21:09; UTC

Uždarbis

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

2026-04-20 21:08; UTC

Uždarbis

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

2026-04-20 21:07; UTC

Uždarbis

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

2026-04-20 21:05; UTC

Uždarbis

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

2026-04-20 21:05; UTC

Uždarbis

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

45.43% į viršų

12 mėnesių prognozė

Vidutinis 131.41 USD  45.43%

Aukščiausias 175 USD

Žemiausias 90 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

18

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

159 / 348 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat